Jana Medical Co.
TTADAWUL:9616Share Statistics
As of December 31, 2024, Jana Medical Co. has 3.21M shares outstanding.
| Shares Outstanding | 3.21M |
Financial Position
As of December 31, 2024, Jana Medical Co. maintains a current ratio of 2.18, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.18 |
| Quick Ratio | 0.45 |
| Interest Coverage | -0.66 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2024. Return on assets (ROA) is negative at -28.51, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -28.51 |
Stock Price Statistics
SARThese figures are as of the close on October 27, 2025. The 50-day moving average sits at 13.92, while the 200-day moving average is 22.33.
| 50-Day Moving Average | 13.92 |
| 200-Day Moving Average | 22.33 |
Margins
Over the twelve months ended December 31, 2024, Jana Medical Co. posted a gross margin of 45.89, reflecting its pricing power and cost economics. The operating margin of -13.97 and net profit margin of -63.13 provide insight into operational efficiency.
| Gross Margin | 45.89 |
| Operating Margin | -13.97 |
| Pretax Margin | -59.26 |
| Profit Margin | -63.13 |
| EBITDA Margin | -13.97 |
Dividends & Yields
These figures cover the twelve months ended December 31, 2024. Total shareholder yield is negative at -7.96, meaning Jana Medical Co. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -7.96 |
Scores
As of December 31, 2024, Jana Medical Co. has an Altman Z-Score of 2.70, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.70 |